Milestone Pharmaceuticals's total assets for Q2 2025 were $47.42M, a decrease of -23.38% from the previous quarter. MIST total liabilities were $65.16M for the fiscal quarter, a -4.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.